Risk of Thrombosis After Stopping Anticoagulation in APS With aPL Negativization -JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Claire Kelly et al., adding:
”Thrombotic Recurrence After Anticoagulation Cessation in Patients with Antiphospholipid Syndrome and Antiphospholipid Antibody Negativization: A Systematic Review and Meta-Analysis
This systematic review and meta-analysis of 55 APS patients who discontinued anticoagulation following aPL negativization reports a pooled thrombotic recurrence rate of 1.61 per 100 person-years, suggesting that aPL negativization may warrant re-evaluation of long-term anticoagulation necessity in carefully selected low-risk patients.”
Title: Contrary to current guidance, antenatal factor IX levels increase in female carriers of hemophilia B
Authors: Claire Kelly, Janet Cleary, Catriona Keenan, Isabelle Delachapelle, Leona Connolly, Mary Byrne, Mairead O’Donovan, Niamh M. O’Connell, James S. O’Donnell, Kevin Ryan, Michelle Lavin
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 5, 2026, 19:35Luise Erpenbeck: When Immune Cells Speak the Language of Neurons
-
Jul 5, 2026, 19:14Mubariz Ahsan: Bringing Stroke Research to a Wider Audience
-
Jul 5, 2026, 18:58Linda Hayes Bennett: Redefining Ferroptosis in Aging and Neurodegenerative Conditions
-
Jul 5, 2026, 18:20LV Aneurysm, Thrombus, and Embolism: A Silent Post-MI Threat – Abdallah Othman
-
Jul 5, 2026, 17:58Andaleb Kholmukhamedov: What’s the Most Unusual “False Positive” Trigger You’ve Seen Elevate a D-Dimer?
-
Jul 5, 2026, 17:47Michiel Coppens: Supporting Better Hemophilia Care in Suriname
-
Jul 5, 2026, 17:31Arrigo Francesco Giuseppe Cicero: Redefining the Role of Urate-Lowering Therapy in Cardiovascular Disease
-
Jul 5, 2026, 17:20Ahmad Gharehbaghian: Iranian Blood Transfusion Organization Engages Government Leaders on Blood Service Investment
-
Jul 5, 2026, 17:03Paolo Zamboni։ New Findings Highlight PLXND1 as a Critical Mechanosensor in Primary Lymphedema